PW MEDTECH GROUP LIMITED Financials PW Medtech Group Limited
Equities
1358
KYG7306W1087
Medical Equipment, Supplies & Distribution
|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 1 HKD | 0.00% |
|
-2.91% | +21.95% |
Valuation
| Fiscal Period: December | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|---|
| Capitalization 1 | 1,405 | 1,977 | 2,840 | 1,279 | 871.1 | 1,167 |
| Enterprise Value (EV) 1 | 1,874 | 2,434 | 1,168 | -1,131 | -512.2 | -426.6 |
| P/E ratio | 0.84 x | 24.1 x | 4.49 x | 1.73 x | 8.22 x | 7.62 x |
| Yield | - | - | - | - | - | 12% |
| Capitalization / Revenue | 4.52 x | 5.46 x | 11.5 x | 4.71 x | 1.62 x | 1.73 x |
| EV / Revenue | 6.03 x | 6.72 x | 4.72 x | -4.17 x | -0.95 x | -0.63 x |
| EV / EBITDA | 22.9 x | 35.1 x | 91.9 x | -14 x | -2.92 x | -1.48 x |
| EV / FCF | 1.51 x | 71.1 x | -0.55 x | -0.51 x | 2.17 x | -1.77 x |
| FCF Yield | 66.2% | 1.41% | -181% | -197% | 46.2% | -56.6% |
| Price to Book | 0.31 x | 0.43 x | 0.56 x | 0.34 x | 0.22 x | 0.29 x |
| Nbr of stocks (in thousands) | 1,569,246 | 1,569,246 | 1,569,246 | 1,569,246 | 1,565,632 | 1,565,632 |
| Reference price 2 | 0.8956 | 1.260 | 1.810 | 0.8148 | 0.5564 | 0.7453 |
| Announcement Date | 4/24/19 | 4/28/20 | 4/23/21 | 4/21/22 | 4/26/23 | 4/25/24 |
1CNY in Million2CNY
Estimates
Income Statement Evolution (Annual data)
| Fiscal Period: December | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|---|
| Net sales 1 | 310.8 | 362.2 | 247.4 | 271.4 | 536.8 | 675.1 |
| EBITDA 1 | 81.84 | 69.27 | 12.71 | 80.86 | 175.5 | 288.8 |
| EBIT 1 | 61.81 | 40.86 | -14.92 | 49.95 | 98.17 | 191.8 |
| Operating Margin | 19.89% | 11.28% | -6.03% | 18.4% | 18.29% | 28.42% |
| Earnings before Tax (EBT) 1 | 126.6 | 85.81 | 626.6 | 737.5 | 157.7 | 231.1 |
| Net income 1 | 1,666 | 81.98 | 631.8 | 739.1 | 106 | 153.2 |
| Net margin | 535.89% | 22.64% | 255.43% | 272.34% | 19.75% | 22.69% |
| EPS 2 | 1.062 | 0.0522 | 0.4026 | 0.4710 | 0.0677 | 0.0978 |
| Free Cash Flow 1 | 1,240 | 34.23 | -2,117 | 2,230 | -236.5 | 241.4 |
| FCF margin | 398.93% | 9.45% | -855.79% | 821.81% | -44.06% | 35.77% |
| FCF Conversion (EBITDA) | 1,514.98% | 49.42% | - | 2,758.32% | - | 83.6% |
| FCF Conversion (Net income) | 74.44% | 41.76% | - | 301.76% | - | 157.62% |
| Dividend per Share | - | - | - | - | - | 0.0894 |
| Announcement Date | 4/24/19 | 4/28/20 | 4/23/21 | 4/21/22 | 4/26/23 | 4/25/24 |
1CNY in Million2CNY
Estimates
Balance Sheet Analysis
| Fiscal Period: December | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|---|
| Net Debt 1 | 469 | 457 | - | - | - | - |
| Net Cash position 1 | - | - | 1,671 | 2,409 | 1,383 | 1,593 |
| Leverage (Debt/EBITDA) | 5.727 x | 6.598 x | - | - | - | - |
| Free Cash Flow 1 | 1,240 | 34.2 | -2,117 | 2,230 | -237 | 241 |
| ROE (net income / shareholders' equity) | 3.11% | 1.8% | 13% | 16.6% | 3.06% | 4.33% |
| ROA (Net income/ Total Assets) | 0.92% | 0.48% | -0.18% | 0.68% | 1.38% | 2.36% |
| Assets 1 | 180,320 | 16,931 | -360,419 | 108,902 | 7,695 | 6,478 |
| Book Value Per Share 2 | 2.860 | 2.940 | 3.260 | 2.420 | 2.520 | 2.580 |
| Cash Flow per Share 2 | 0.0600 | 0.0800 | 1.080 | 1.460 | 0.8800 | 1.020 |
| Capex 1 | 124 | 47.4 | 7.88 | 11.3 | 52.5 | 47.3 |
| Capex / Sales | 39.8% | 13.08% | 3.18% | 4.17% | 9.77% | 7.01% |
| Announcement Date | 4/24/19 | 4/28/20 | 4/23/21 | 4/21/22 | 4/26/23 | 4/25/24 |
1CNY in Million2CNY
Estimates
EPS & Dividend
Year-on-year evolution of the PER
Change in Enterprise Value/EBITDA
Annual profits - Rate of surprise
| 1st Jan change | Capi. | |
|---|---|---|
| +21.95% | 201M | |
| +10.10% | 27.85B | |
| -30.75% | 3.09B | |
| +35.19% | 2.66B | |
| -18.85% | 2.44B | |
| +6.85% | 2.24B | |
| -4.71% | 2.02B | |
| +33.33% | 2.05B | |
| +34.05% | 1.35B | |
| +3.25% | 1.33B |
- Stock Market
- Equities
- 1358 Stock
- Financials PW Medtech Group Limited
